TR200000854T2 - Yüksek tripeptid, lactobacıllus helvetıcus bakterileri ve bunların hazırlanması - Google Patents

Yüksek tripeptid, lactobacıllus helvetıcus bakterileri ve bunların hazırlanması

Info

Publication number
TR200000854T2
TR200000854T2 TR2000/00854T TR200000854T TR200000854T2 TR 200000854 T2 TR200000854 T2 TR 200000854T2 TR 2000/00854 T TR2000/00854 T TR 2000/00854T TR 200000854 T TR200000854 T TR 200000854T TR 200000854 T2 TR200000854 T2 TR 200000854T2
Authority
TR
Turkey
Prior art keywords
pro
less
lineage
lactobacillus helveticus
milk
Prior art date
Application number
TR2000/00854T
Other languages
English (en)
Inventor
Yamamoto Naoyuki
Kawakami Natsue
Ishida Yuu
Yada Hirokazu
Original Assignee
Calpis Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calpis Co., Ltd. filed Critical Calpis Co., Ltd.
Publication of TR200000854T2 publication Critical patent/TR200000854T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/137—Thickening substances
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/147—Helveticus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dairy Products (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Bu bulus, yüksek miktarlarda lakotripeptid ve hipotensif ve stres rahatlatici falaliyetlere sahip bir dizi madde ihtiva eden ve kolaylikla yenebilen ve yutulabilen bir fermante süt ürünü üretme yetenegine sahip bir laktik bakteriler soyu ile ilgilidir. Daha spesifik olarak bu bulus lactobacillus helvecus cinsinden bir laktik bakteri, yani agirligin % 9'undan az olmamak üzere (kati muhteviyat açisindan ) yagsiz süt ihtiva eden hayvan sütünde kükürtlendigi zaman val-Pro-Pro açisindan 60 mg/ml'den az olmamak üzere VaPro-Pro ve/ya da Ile- Pro-Pro tripeptidlerini üretmek için özel mikolojik özelliklere sahip olmasi ile karekterize edilen ve 400 U/OD 590'dan daha az olmayan bir hücre disi proteaz faaliyeti gösteren Lactobacillus helveticus soy CM4 (National Institute of BBioscience and Human Technology nezdinde FERM PB-6060 erisim numarasi altinda tevdi edilmis); ve hayvan sütünü yukarida bahsedilen laktik bakteri ile fermante ederek hazirlanan bir fermante süt ürünü ile ilgilidir.
TR2000/00854T 1997-09-26 1998-02-05 Yüksek tripeptid, lactobacıllus helvetıcus bakterileri ve bunların hazırlanması TR200000854T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9277949A JP3028411B2 (ja) 1997-09-26 1997-09-26 トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌

Publications (1)

Publication Number Publication Date
TR200000854T2 true TR200000854T2 (tr) 2000-07-21

Family

ID=17590526

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00854T TR200000854T2 (tr) 1997-09-26 1998-02-05 Yüksek tripeptid, lactobacıllus helvetıcus bakterileri ve bunların hazırlanması

Country Status (24)

Country Link
US (2) US6534304B1 (tr)
EP (1) EP1016709B1 (tr)
JP (1) JP3028411B2 (tr)
KR (1) KR100404154B1 (tr)
CN (1) CN1149279C (tr)
AR (1) AR017153A1 (tr)
AT (1) ATE294230T1 (tr)
AU (1) AU734422B2 (tr)
BG (1) BG64422B1 (tr)
BR (1) BR9813218A (tr)
CA (1) CA2304985C (tr)
CZ (1) CZ291067B6 (tr)
DE (1) DE69829983T2 (tr)
ES (1) ES2237834T3 (tr)
HU (1) HU225980B1 (tr)
IN (1) IN188418B (tr)
MY (1) MY118157A (tr)
PL (1) PL188675B1 (tr)
PT (1) PT1016709E (tr)
SK (1) SK284755B6 (tr)
TR (1) TR200000854T2 (tr)
TW (1) TW526268B (tr)
WO (1) WO1999016862A1 (tr)
ZA (1) ZA988659B (tr)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ513305A (en) * 1999-01-11 2003-06-30 Calpis Co High yield production of curds and whey containing an ACE inhibitor peptide (val-pro-pro and/or ile-pro-pro) made under stirring conditions
FR2793257B1 (fr) 1999-05-06 2001-07-27 Gervais Danone Sa Bacteries lactiques a proprietes anxiolytiques, et leurs utilisations
FI113741B (fi) 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
JP4633876B2 (ja) 1999-11-11 2011-02-16 カルピス株式会社 トリペプチドの製造方法
FI112031B (fi) 2002-02-25 2003-10-31 Valio Oy Biologisesti aktiivisen tuotteen uusi käyttö
WO2003082019A2 (en) * 2002-04-03 2003-10-09 Chr. Hansen A/S Peptides with anti-hypertensive properties
EP1529114A1 (en) * 2002-08-09 2005-05-11 Chr. Hansen A/S Process for preparing peptides with anti-hypertensive properties
WO2004060073A1 (en) 2003-01-06 2004-07-22 Unilever N.V. Fermented milk product comprising tripeptide vpp and/or ipp
TWI411441B (zh) * 2003-03-18 2013-10-11 Suntory Holdings Ltd 血管收縮素轉化酶抑制性肽類
US7718171B2 (en) 2003-04-07 2010-05-18 Chr. Hansen A/S Reducing heart rate in mammals using milk derived fermentation products produced using Lactobacillus helveticus
AU2004237455B2 (en) 2003-05-05 2007-08-02 Dsm Ip Assets B.V. Hydrolysed casein product comprising tripeptides IPP and/ or VPP
JP4680571B2 (ja) * 2003-12-25 2011-05-11 カルピス株式会社 経口摂取用保湿剤
TW200533299A (en) * 2004-03-31 2005-10-16 Calpis Co Ltd Functional food for improving endogenous rhythm of melatonin secretion, and functional food for improving circadian rhythm
WO2005094848A1 (ja) * 2004-03-31 2005-10-13 Calpis Co., Ltd. 肝障害予防又は抑制剤及び肝障害予防又は抑制用機能性食品
WO2006004105A1 (ja) * 2004-07-05 2006-01-12 Calpis Co., Ltd. ペプチド混合物の製造法、抗高血圧ペプチド含有発酵乳の製造法及び抗高血圧ペプチド製剤の製造法
JP2008511593A (ja) 2004-09-03 2008-04-17 セーホーエル．ハンセン アクティーゼルスカブ 受容体リガンドを含む発酵乳又は植物性タンパク質及びその使用
WO2006095764A1 (ja) * 2005-03-09 2006-09-14 Calpis Co., Ltd. 皮膚における紫外線感受性抑制剤及び機能性飲食品
US8097246B2 (en) 2005-06-24 2012-01-17 Calpis Co., Ltd. Promoter of differentiation and keratinization of epidermic cell and functional beverage/food for promotion of keratinization of epidermis
EP1908354A4 (en) * 2005-07-26 2011-12-28 Calpis Co Ltd PROCESS FOR THE PRODUCTION OF FERMENTED MILK AND BEVERAGE / FOOD PRODUCT FOR FERMENTED MILK
CN1903052B (zh) * 2005-07-26 2010-04-28 天津科技大学 具有酪蛋白磷酸肽、抗血管紧张素转化酶肽和低聚半乳糖乳清粉的制备方法
TW200808338A (en) * 2006-02-14 2008-02-16 Calpis Co Ltd Vasodilator and functional food
JP5642346B2 (ja) * 2006-02-14 2014-12-17 カルピス株式会社 動脈硬化予防剤、血管内膜の肥厚抑制剤及び血管内皮の収縮・拡張機能改善剤
ATE548445T1 (de) * 2006-02-20 2012-03-15 Gervais Danone Sa Laktose nicht fermentierende lactobacillus helveticus
DK1820850T3 (da) * 2006-02-20 2009-06-29 Gervais Danone Sa Nye stammer af Lactobacillus Helveticus
PT1820849E (pt) 2006-02-20 2009-04-24 Gervais Danone Sa Novas estirpes de lactobacillus helveticus
ATE503388T1 (de) * 2006-02-20 2011-04-15 Gervais Danone Sa Neue lactobacillus helveticus stämme
JP2009537492A (ja) * 2006-05-15 2009-10-29 ヴァリオ・リミテッド 治療上有用なペプチドの新規用途
ES2610811T3 (es) 2006-06-16 2017-05-03 Dupont Nutrition Biosciences Aps Bacteria Streptococcus thermophilus
KR101492650B1 (ko) * 2006-09-04 2015-02-12 유키지루시 메그밀크 가부시키가이샤 혈중 아디포넥틴 농도 증가 촉진 및/또는 감소 억제제 및 내장 지방 축적 억제제
JP2008214253A (ja) 2007-03-02 2008-09-18 Snow Brand Milk Prod Co Ltd 内臓脂肪減少剤
EA016808B1 (ru) 2007-03-27 2012-07-30 Калпис Ко., Лтд. ПРИМЕНЕНИЕ ТРИПЕПТИДОВ Val Pro Pro И Ile Pro Pro ДЛЯ СУПРЕССИИ УТОЛЩЕНИЯ СТЕНКИ СЕРДЦА
TWI414305B (zh) * 2007-03-27 2013-11-11 Calpis Co Ltd 腎衰竭預防劑
AU2009256950A1 (en) * 2008-06-12 2009-12-17 Nestec S.A. Lactobacillus helveticus strains for producing hypotensive peptides
ES2381426T3 (es) * 2008-12-29 2012-05-28 Unilever N.V. Productos de confitura congelados y bebidas que comprenden teobromina y cafeína
WO2011095389A1 (en) * 2010-02-04 2011-08-11 Unilever Nv Use of theobromine for lowering central blood pressure
AU2011254726B2 (en) 2010-05-19 2014-03-06 Upfield Europe B.V. Theobromine for increasing HDL-cholesterol
JP2010183918A (ja) * 2010-06-01 2010-08-26 Calpis Co Ltd トリペプチドの製造方法
JP5797891B2 (ja) * 2010-11-09 2015-10-21 カルピス株式会社 Ｎｏｎ−ｄｉｐｐｅｒ型血圧日内変動による疾病発症リスク軽減剤
WO2012063826A1 (ja) * 2010-11-09 2012-05-18 カルピス株式会社 高タンパク質分解活性を有するラクトバチルス・ヘルベティカス菌
RU2453593C1 (ru) * 2011-04-21 2012-06-20 Общество с ограниченной ответственностью "Бифилюкс" Штамм lactobacillus helveticus, используемый для получения продукции, содержащей лактобактерии
US20120328735A1 (en) * 2011-06-24 2012-12-27 Naoto Uchida Process for preparing casein-derived peptides by fermentation of lactic acid bacteria
DE202012012998U1 (de) 2011-08-31 2014-06-13 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels
NZ704190A (en) 2012-08-22 2018-04-27 Kraft Foods Group Brands Llc Processed cheese with cultured dairy components and method of manufacturing
CN102960444A (zh) * 2012-11-19 2013-03-13 陕西科技大学 一种基于瑞士乳杆菌发酵的含ace抑制肽的羊奶的制备方法
CN104450574B (zh) * 2014-12-10 2017-05-10 生合生物科技（南京）有限公司 一种瑞士乳杆菌lh43及其制作乳酸菌饮料的方法
RU2577112C1 (ru) * 2014-12-25 2016-03-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" Штамм lactobacillus helveticus вкпм в-11175, полученный на доступных питательных средах
CN107674848A (zh) * 2017-09-20 2018-02-09 云南乍甸乳业有限责任公司 一种酸奶发酵菌种的制备方法
CN111227049B (zh) * 2018-11-29 2022-08-12 内蒙古伊利实业集团股份有限公司 一种维持褐色植物基酸奶货架期内组织状态稳定性的方法
CN109517763B (zh) * 2018-12-27 2022-03-22 内蒙古农业大学 瑞士乳杆菌h11及其应用
CN110226687A (zh) * 2019-06-12 2019-09-13 宁波依萃健生物科技有限公司 一种解酒护肝组合物及制备方法
EP3845069B1 (en) 2019-12-30 2022-08-24 Compagnie Gervais Danone Sucrose negative streptococcus thermophilus for use in preparation of fermented products
CN111979286B (zh) * 2020-08-31 2021-11-26 鲁东大学 一种发酵法与酶法联合制备贝类高f值寡肽的方法
CN112616925A (zh) * 2020-12-30 2021-04-09 光明乳业股份有限公司 一种双蛋白发酵乳及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3846560A (en) * 1971-07-22 1974-11-05 Quaker Oats Co Process of making a base for protein beverages
US3876806A (en) * 1971-10-14 1975-04-08 Quaker Oats Co Process for the preparation of acid soluble polypeptides and carbonated beverages containing same
US4107334A (en) * 1976-10-13 1978-08-15 Pfizer Inc. Modified protein
CH636248A5 (fr) * 1979-03-09 1983-05-31 Nestle Sa Procede de preparation d'un hydrolysat de proteines purifie.
JPS60262561A (ja) * 1984-06-08 1985-12-25 House Food Ind Co Ltd 大豆蛋白質水溶液の処理方法
US4585757A (en) * 1984-07-27 1986-04-29 Texas Tech University Health Sciences Center Hypotensive active peptides
US4687840A (en) * 1986-02-11 1987-08-18 Texas Tech University Health Sciences Center Hypotensive active peptides
GB8823429D0 (en) * 1988-10-05 1988-11-09 Agricultural Genetics Co Method for accelerated ripening of cheddar & related hard type cheese
MY109493A (en) * 1989-07-07 1997-02-28 Nestle Sa Protein hydrolysis.
NL9000422A (nl) * 1990-02-21 1991-09-16 Nl Zuivelonderzoek Inst Werkwijze voor de bereiding van een gefermenteerd melkprodukt.
EP0445606B1 (en) * 1990-02-27 1997-01-22 The Agency of Industrial Science and Technology Novel oligopeptides, pharmaceutical composition and food containing the same, and use of oligopeptides
DE69127020T2 (de) * 1990-05-18 1998-01-29 Iwase Cosfa Co Ltd Milchproteinhydrolysate und Zusammensetzungen zur Verwendung als Haar- und Hautbehandlungsmittel
JP2571734B2 (ja) * 1991-08-23 1997-01-16 株式会社ヤクルト本社 乳酸菌飲料
US5486461A (en) * 1991-11-08 1996-01-23 Novo Nordisk A/S Casein hydrolyzate and method for production of such casein hydrolyzate
FI94088C (fi) * 1992-03-13 1995-07-25 Valio Oy Menetelmä fenyylialaniinin poistamiseksi proteiinipitoisista koostumuksista
US5418218A (en) * 1992-07-10 1995-05-23 The University Of Maryland At Baltimore Histidyl-proline diketopiperazine (cyclo his-pro) a cns-active pharmacologic agent
JP2782142B2 (ja) * 1992-07-23 1998-07-30 カルピス株式会社 アンジオテンシン変換酵素阻害剤及びその製造法
JP2782153B2 (ja) * 1992-11-09 1998-07-30 カルピス株式会社 アンジオテンシン変換酵素阻害ペプチドの製造法
US5656268A (en) * 1995-04-21 1997-08-12 Sorodsky; Michael Biological product
US5618689A (en) * 1995-05-25 1997-04-08 Nestec S.A. Enhanced procedures for preparing food hydrolysates
WO1998027827A1 (en) * 1996-12-23 1998-07-02 Dsm N.V. Method for producing a protein hydrolysate
US6221423B1 (en) * 1998-04-13 2001-04-24 Protein Technologies Int'l Inc. Short-chained peptide material
WO2001068114A1 (en) 2000-03-10 2001-09-20 Monsanto Company Novel peptides with anti-hypertensive activity
AU2001245537A1 (en) 2000-03-10 2001-09-24 Monsanto Company Anti-hypertensive peptides
US6908633B2 (en) 2000-03-13 2005-06-21 Morinaga Milk Industry Co., Ltd. Protein hydrolyzates, process for producing the same and drinks and foods containing the protein hydrolyzates
US20030040475A1 (en) 2001-01-16 2003-02-27 Yasuhiro Toba Agents for improving lipid metabolism and reducing high blood pressure
US6815426B2 (en) 2001-02-16 2004-11-09 E. I. Du Pont De Nemours And Company Angiogenesis-inhibitory tripeptides, compositions and their methods of use
WO2002071854A1 (en) 2001-03-09 2002-09-19 Unilever N.V. Fermented milk product
US6589574B2 (en) 2001-03-19 2003-07-08 Council Of Scientific & Industrial Research Process for preparation of protein-hydrolysate from milk protein

Also Published As

Publication number Publication date
PT1016709E (pt) 2005-08-31
HU225980B1 (en) 2008-02-28
DE69829983D1 (de) 2005-06-02
EP1016709B1 (en) 2005-04-27
PL188675B1 (pl) 2005-03-31
KR100404154B1 (ko) 2003-11-01
PL339343A1 (en) 2000-12-18
DE69829983T2 (de) 2006-05-04
WO1999016862A1 (en) 1999-04-08
IN188418B (tr) 2002-09-21
CN1279712A (zh) 2001-01-10
US6534304B1 (en) 2003-03-18
SK284755B6 (sk) 2005-11-03
BR9813218A (pt) 2000-08-29
US20030064501A1 (en) 2003-04-03
HUP0003744A2 (en) 2001-03-28
KR20010024311A (ko) 2001-03-26
AR017153A1 (es) 2001-08-22
EP1016709A4 (en) 2002-09-11
HUP0003744A3 (en) 2001-11-28
JP3028411B2 (ja) 2000-04-04
BG64422B1 (bg) 2005-01-31
EP1016709A1 (en) 2000-07-05
CN1149279C (zh) 2004-05-12
US7282354B2 (en) 2007-10-16
AU5780298A (en) 1999-04-23
MY118157A (en) 2004-09-30
CA2304985C (en) 2007-05-08
BG104382A (en) 2000-12-29
ES2237834T3 (es) 2005-08-01
JPH1198978A (ja) 1999-04-13
TW526268B (en) 2003-04-01
SK4352000A3 (en) 2001-05-10
CZ291067B6 (cs) 2002-12-11
CZ20001082A3 (cs) 2001-01-17
CA2304985A1 (en) 1999-04-08
AU734422B2 (en) 2001-06-14
ATE294230T1 (de) 2005-05-15
ZA988659B (en) 1999-03-31

Similar Documents

Publication Publication Date Title
TR200000854T2 (tr) Yüksek tripeptid, lactobacıllus helvetıcus bakterileri ve bunların hazırlanması
US6596530B1 (en) Strain of Lactobacillus gasseri
Fuller Probiotics 2: applications and practical aspects
RU2308483C2 (ru) Штамм bifidobacterium longum infantis для приготовления пробиотика, антимикробный агент и препарат на основе штамма bifidobacterium longum infantis с иммуномодулирующими свойствами
Kailasapathy et al. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp.
RU2126446C1 (ru) Штамм молочнокислых бактерий lactobacillus acidophilus и композиция против диареи
EP1005353A1 (en) Pharmaceutical preparation comprising lactobacillus casei rhamnosus
NZ518493A (en) Lactobacillus helvetius producing antihypertensive DI- and tripeptides
CN100455203C (zh) 包含至少两种能定居在胃肠道中以及具有肠存活特性,肠结合特性,感染保护特性和纤维发酵特性的乳酸菌株的益生菌组合物
CZ301673B6 (cs) Kombinace probiotik a její použití
US20110262400A1 (en) Probiotic bacterial molecules and their use in methods to treat/prevent infection by harmful bacteria and to provide nutritional health
RO121005B1 (ro) Încorporarea de bacterii lactice, exogene, în microflora bucală
IL212698A (en) Pharmacotherapy for the prevention and treatment of infections caused by staphylococcus and other aspects based on this drug
Pandya Benefits of probiotics in oral cavity–A detailed review
CN100370019C (zh) 一种具有抗高血压作用的植物乳杆菌cw006
JP2010006757A (ja) 経口摂取用皮膚性状改善剤
JP5544234B2 (ja) 歯周病菌生育抑制用組成物
OA12074A (en) Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis.
WO2006073329A1 (en) Bifidobacterium lactis 668 strain used for ar a component for food products, starters, medicinal and cosmetic agents
JP2006508943A (ja) 酵母成長を阻害するための方法
JP2009125055A (ja) ビフィズス菌および乳酸菌の増殖促進剤
JP7699342B2 (ja) Ｓｉｒｔ１遺伝子発現誘導用製剤
CN106036082B (zh) 一种抗猪腹泻的无抗饲料
KR100808956B1 (ko) 김치로부터 분리된 유산균 및 이로부터 얻어지는 엑소폴리사카라이드
Saxelin Development of dietary probiotics: Estimation of optimal Lactobacillus GG concentrations.